Care
HIMSS Media Editor in Chief Jonah Comstock looks at November's biggest stories, including news from the FDA and CMS, and Amazon's strategies going forward.
The digital tool will be first marketed in Taiwan following regulatory approvals.
The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.
Vayyar and Assistive Technology Service (ATS) are options for fall-detection devices as part of the Alexa Together subscription that allows caregivers to remotely assist family members.
The Series A will support Proov’s new Complete testing product.
The fund seeks to capitalise on Europe’s rapidly expanding digital health landscape.
A new 3D-printed capsule planned for assisted suicide is being legalised in Switzerland.
The company, backed by Summer VC, plans to launch in early 2022.
The company also launched a tracker that can gather data about a child's progress.
The prescription digital therapeutics company said the transaction generated approximately $175 million.